Korro Bio, Inc. (KRRO) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -106.64M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-106.64M | (m) |
| 2026-03-31 | (m) | $-113.50M | (m) |
| 2025-12-31 | (m) | $-117.26M | (m) |
| 2025-09-30 | (m) | $-88.42M | (m) |
| 2025-06-30 | (m) | $-91.36M | (m) |
| 2025-03-31 | (m) | $-87.41M | (m) |
| 2024-12-31 | (m) | $-83.58M | (m) |
| 2024-09-30 | (m) | $-87.81M | (m) |
| 2024-06-30 | (m) | $-85.30M | (m) |
| 2024-03-31 | (m) | $-81.12M | (m) |
| 2023-12-31 | (m) | $-81.17M | (m) |
| 2023-09-30 | (m) | $-59.31M | (m) |
| 2023-06-30 | (m) | $-67.25M | (m) |
| 2023-03-31 | (m) | $-77.74M | (m) |
| 2022-12-31 | (m) | $-81.58M | (m) |
| 2022-09-30 | (m) | $-85.72M | (m) |
| 2022-06-30 | (m) | $-91.33M | (m) |
| 2022-03-31 | (m) | $-87.70M | (m) |
| 2021-12-31 | (m) | $-84.69M | (m) |
| 2021-09-30 | (m) | $-73.42M | (m) |
| 2021-06-30 | (m) | $-53.60M | (m) |
| 2021-03-31 | (m) | $-41.97M | (m) |
| 2020-12-31 | (m) | $-26.51M | (m) |
| 2020-09-30 | (m) | $-21.77M | (m) |
| 2020-06-30 | (m) | $-17.01M | (m) |
| 2020-03-31 | (m) | $-17.83M | (m) |
| 2019-12-31 | (m) | $-18.75M | (m) |
| 2019-09-30 | (m) | (m) | (m) |
| 2019-06-30 | (m) | $-23.26M | (m) |
| 2019-03-31 | (m) | $-20.84M | (m) |
| 2018-12-31 | (m) | $-19.17M | (m) |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) |
| 2017-12-31 | (m) | $-20.24M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |